Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Global X S&P Biotech ETF (CURE.AX)

40.08
-0.67
(-1.64%)
At close: 2:23:38 PM GMT+10

Top 10 Holdings (25.12% of Total Assets)

SymbolCompany% Assets
ALNY
Alnylam Pharmaceuticals, Inc. 2.75%
INSM
Insmed Incorporated 2.62%
NBIX
Neurocrine Biosciences, Inc. 2.58%
UTHR
United Therapeutics Corporation 2.48%
NTRA
Natera, Inc. 2.47%
VRTX
Vertex Pharmaceuticals Incorporated 2.47%
BIIB
Biogen Inc. 2.45%
AMGN
Amgen Inc. 2.44%
GILD
Gilead Sciences, Inc. 2.44%
ABBV
AbbVie Inc. 2.41%

Sector Weightings

SectorCURE.AX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.85%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.31
Price/Sales 0.17
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

null

ETF Overview

Category --
Fund Family Global X Management (AUS) Ltd
Net Assets 31.21M
YTD Daily Total Return -17.68%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers